Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Radiation Oncology
•
Thoracic Malignancies
What is your approach to patients with T4 NSCLC due to several ipsilateral lung nodules in different lobes?
For example, 5 PET-positive lesions, 2 lesions biopsied and both of the same histology.
Related Questions
Would you treat an in-field recurrence/marginal recurrence of NSCLC following previous definitive chemoradiation with salvage SBRT?
Are there situations in which neoadjuvant chemoimmunotherapy + surgery would be preferred over chemoradiation + adjuvant immunotherapy for stage III lung cancer?
How many missed fractions will you allow for a definitive lung CRT before recommending treatment on the weekend?
How would you approach synchronous node positive NSCLC and anal primaries?
How would you approach radiation for a patient with limited stage small cell lung cancer who refuses chemotherapy?
How do you approach management of newly diagnosed locally advanced NSCLC in patients who are intubated for respiratory failure due to their disease burden?
Do you recommend holding a KRAS inhibitor during palliative radiotherapy?
How do you manage a supraclavicular only recurrence in NSCLC previously treated with chemoradiation for Stage III disease?
For consideration of empiric lung SBRT without pathology, do you use a preferred nomogram to guide this decision?
For locally advanced NSCLC with additional synchronous NSCLC primaries in the same lung or lobe, what is your approach to definitive therapy?